Anthropic quietly sets up biology lab as it ramps AI drug program: Reuters
Amid AI fears, Anthropic has set up a lab for physical biology experiments as it forays into drug science in a quest to cure rare diseases.
San Francisco-based Anthropic has quietly established a laboratory to conduct physical biology research as it expands its artificial intelligence focus towards drug science. As concerns about AI grow among the public, the startup has established a wet lab in the San Francisco Bay Area, according to two sources familiar with the situation.
Anthropic has expressed its goal of developing treatments for rare diseases, and its biology work has moved beyond purely computer-based simulations. Eric Kauderer-Abrams, Anthropic's head of life sciences, confirmed the existence of the company's wet lab in a recent Reuters interview, stating that the final tests for biology still involve laboratory experiments in the foreseeable future.
He further explained that Anthropic is pursuing a conventional biotech approach, involving some experiments in-house and collaborating with external partners on other aspects. The company's spokesperson later clarified that the wet lab is not exclusively dedicated to drug discovery.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Anthropic quietly sets up biology lab as it ramps AI drug program koreatimes.co.kr
